Amgen
Amgen, founded in 1980 in Thousand Oaks, California, is a global biotechnology company that develops innovative medicines and has a significant presence in key biotech hubs.
Company History
Amgen was founded in 1980 in Thousand Oaks, California. Over the decades, it has grown to operate in approximately 100 countries worldwide. Its significant presence includes biotechnology hubs such as South San Francisco and Cambridge, Massachusetts. Amgen's growth has been supported by key collaborations and acquisitions, enhancing its product portfolio and research capabilities.
Biotechnology and Medicine Development
Amgen focuses on leveraging biotechnology to develop innovative medicines. It utilizes state-of-the-art science and molecular engineering to maintain a robust pipeline of medical solutions. This commitment to advancing medical science positions Amgen as a leader in the biotechnology sector.
Biosimilars Development and Commercialization
Amgen engages actively in the development and commercialization of biosimilars. By producing these alternatives to existing biologic drugs, Amgen expands its impact within the pharmaceutical industry, offering more treatment options and contributing to the accessibility of essential medications.
Next-Generation Biomanufacturing
Amgen operates a next-generation biomanufacturing plant in Singapore. This facility represents the company's commitment to cutting-edge production technology and innovation in biomanufacturing. The plant enhances Amgen's ability to produce high-quality medicines efficiently.
Corporate Social Responsibility and Sustainability
Amgen is committed to environmental sustainability and reducing its environmental impact. This commitment is reflected in various initiatives and practices aimed at promoting sustainability. Additionally, the Amgen Foundation supports a range of educational and community investment programs, underlining the company's dedication to social responsibility and community engagement.